Cosmetics Diversified Stock Analysis: 1999
This article was originally published in The Rose Sheet
Executive Summary
1999 Performance Of Toiletries, Fragrances And Skin Care Stocks (11 Cosmetics and 10 Diversifieds) Used In "The Rose Sheet" Index: High, Low And Close For The Yea
You may also be interested in...
Avon CEO Selection, Growth Plan Sparks 33% Fourth Quarter Stock Runup
Avon's much-anticipated appointment of Andrea Jung to CEO coupled with her unveiling of the direct-seller's forward-looking business plan made the stock an eleventh-hour winner on Wall Street in 1999.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.